To construct the bispecific cell engager MSLN×CD16A, we utilized the SpyTag/SpyCatcher protein conjugation system (Fig. 2a) to combine MSLN-SpyCatcher (for tumor localization and aggregation) and CD16A-SpyTag (for immune activation) at a molecular ratio of 1:1. Here, MSLN is linked to neoplasm.